Bob Brousseau

Bob Brousseau is a seasoned consultant at Russell Reynolds Associates, specializing in the healthcare sector with a focus on medical devices and diagnostics. With over 20 years of experience in the pharmaceuticals and diagnostics industries, he has established himself as a key figure in providing tailored advisory solutions to clients.

Professional Background

Bob has architected several successful commercial turnarounds as an operating executive before joining Russell Reynolds Associates.2 His expertise spans various areas, including:

• Turn Arounds
• Start-ups
• Product Launches
• Clinical settings

Throughout his career, Bob has held leadership positions at notable organizations such as Veridia Clinical Laboratory, Agendia, and Genoptix, showcasing his versatility in sales, marketing, and operations.

Specializations

Bob's therapeutic focus is broad, covering areas like:

• Oncology
• Cardiovascular diseases
• Epilepsy
• Rheumatoid Arthritis
• Leukemia
• Breast Cancer
• HPV

His product knowledge encompasses a wide range of medications and treatments, including Compass, Savella, Twinject, Methotrexate, and Tranxene, among others.

Education

Bob holds strong educational credentials:

• MBA in Marketing from Southern Methodist University
• BBA in Finance from the University of Oklahoma4

Role at Russell Reynolds Associates

As a consultant at Russell Reynolds Associates, Bob is part of the firm's Healthcare Practice.3 He leverages his extensive experience to:

• Recruit and assess top talent
• Contribute to executive, board, and C-suite searches
• Advise on succession planning and board evaluation
• Provide insights on transformation strategies1

Bob's expertise and background make him a valuable asset to Russell Reynolds Associates, particularly in their Dallas office, where he contributes to the firm's growing platform in various sectors including Healthcare, Industrial, and Consumer markets.1